Logo image of LYB

LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LYB - NL0009434992 - Common Stock

50.43 USD
+1.57 (+3.21%)
Last: 1/21/2026, 12:07:08 PM
Fundamental Rating

3

Taking everything into account, LYB scores 3 out of 10 in our fundamental rating. LYB was compared to 82 industry peers in the Chemicals industry. LYB may be in some trouble as it scores bad on both profitability and health. LYB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year LYB was profitable.
  • LYB had a positive operating cash flow in the past year.
  • LYB had positive earnings in each of the past 5 years.
  • LYB had a positive operating cash flow in each of the past 5 years.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • LYB's Return On Assets of -3.59% is on the low side compared to the rest of the industry. LYB is outperformed by 67.07% of its industry peers.
  • LYB has a Return On Equity of -11.44%. This is in the lower half of the industry: LYB underperforms 67.07% of its industry peers.
  • The Return On Invested Capital of LYB (3.64%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for LYB is above the industry average of 6.11%.
  • The 3 year average ROIC (10.69%) for LYB is well above the current ROIC(3.64%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROIC 3.64%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • LYB's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 3.65%, LYB is doing worse than 64.63% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LYB has declined.
  • The Gross Margin of LYB (9.19%) is worse than 84.15% of its industry peers.
  • LYB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.65%
PM (TTM) N/A
GM 9.19%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LYB is creating some value.
  • The number of shares outstanding for LYB remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, LYB has less shares outstanding
  • LYB has a worse debt/assets ratio than last year.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • LYB has an Altman-Z score of 1.93. This is not the best score and indicates that LYB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LYB has a Altman-Z score (1.93) which is in line with its industry peers.
  • The Debt to FCF ratio of LYB is 16.07, which is on the high side as it means it would take LYB, 16.07 years of fcf income to pay off all of its debts.
  • LYB has a Debt to FCF ratio (16.07) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that LYB has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.02, LYB is doing worse than 67.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Altman-Z 1.93
ROIC/WACC0.46
WACC7.9%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.57 indicates that LYB should not have too much problems paying its short term obligations.
  • LYB has a worse Current ratio (1.57) than 67.07% of its industry peers.
  • LYB has a Quick Ratio of 1.57. This is a bad value and indicates that LYB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • LYB has a Quick ratio of 0.93. This is in the lower half of the industry: LYB underperforms 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.93
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

  • The earnings per share for LYB have decreased strongly by -61.51% in the last year.
  • LYB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.75% yearly.
  • LYB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.07%.
  • LYB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.02% yearly.
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.03% on average over the next years.
  • The Revenue is expected to decrease by -6.25% on average over the next years.
EPS Next Y-63.95%
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%
EPS Next 5Y5.03%
Revenue Next Year-25.58%
Revenue Next 2Y-14.15%
Revenue Next 3Y-9.56%
Revenue Next 5Y-6.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

  • LYB is valuated rather expensively with a Price/Earnings ratio of 18.61.
  • The rest of the industry has a similar Price/Earnings ratio as LYB.
  • LYB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.94, which is the current average of the S&P500 Index.
  • LYB is valuated correctly with a Price/Forward Earnings ratio of 15.15.
  • 63.41% of the companies in the same industry are more expensive than LYB, based on the Price/Forward Earnings ratio.
  • LYB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.94.
Industry RankSector Rank
PE 18.61
Fwd PE 15.15
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LYB's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 68.29% of the companies in the same industry are more expensive than LYB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.99
EV/EBITDA 9.94
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • A cheap valuation may be justified as LYB's earnings are expected to decrease with -10.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 10.77%, LYB is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.28, LYB pays a better dividend. On top of this LYB pays more dividend than 95.12% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.77%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.17%.
  • LYB has been paying a dividend for at least 10 years, so it has a reliable track record.
  • LYB has decreased its dividend recently.
Dividend Growth(5Y)5.17%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

  • LYB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • LYB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-144.93%
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

LYONDELLBASELL INDU-CL A

NYSE:LYB (1/21/2026, 12:07:08 PM)

50.43

+1.57 (+3.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-31
Earnings (Next)01-30
Inst Owners71.84%
Inst Owner Change0.11%
Ins Owners0.18%
Ins Owner Change-0.03%
Market Cap16.23B
Revenue(TTM)32.56B
Net Income(TTM)-1.21B
Analysts53.79
Price Target49.87 (-1.11%)
Short Float %8.21%
Short Ratio3.75
Dividend
Industry RankSector Rank
Dividend Yield 10.77%
Yearly Dividend5.31
Dividend Growth(5Y)5.17%
DP-144.93%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.36%
Min EPS beat(2)-23.45%
Max EPS beat(2)24.17%
EPS beat(4)2
Avg EPS beat(4)-4.8%
Min EPS beat(4)-23.45%
Max EPS beat(4)24.17%
EPS beat(8)4
Avg EPS beat(8)-1.26%
EPS beat(12)8
Avg EPS beat(12)5.26%
EPS beat(16)10
Avg EPS beat(16)2.78%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)0.76%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)-0.64%
Revenue beat(16)10
Avg Revenue beat(16)0.42%
PT rev (1m)-8.84%
PT rev (3m)-18.52%
EPS NQ rev (1m)-66.98%
EPS NQ rev (3m)-75.52%
EPS NY rev (1m)-12.99%
EPS NY rev (3m)-8.77%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-4.51%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE 18.61
Fwd PE 15.15
P/S 0.5
P/FCF 21.99
P/OCF 6.08
P/B 1.53
P/tB 1.72
EV/EBITDA 9.94
EPS(TTM)2.71
EY5.37%
EPS(NY)3.33
Fwd EY6.6%
FCF(TTM)2.29
FCFY4.55%
OCF(TTM)8.3
OCFY16.45%
SpS101.16
BVpS32.93
TBVpS29.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.81
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROCE 4.41%
ROIC 3.64%
ROICexc 3.89%
ROICexgc 4.08%
OM 3.65%
PM (TTM) N/A
GM 9.19%
FCFM 2.27%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
ROICexc(3y)11.83%
ROICexc(5y)12.68%
ROICexgc(3y)12.95%
ROICexgc(5y)13.92%
ROCE(3y)12.98%
ROCE(5y)14.24%
ROICexgc growth 3Y-25.81%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-25.6%
ROICexc growth 5Y-8.64%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Debt/EBITDA 4.18
Cap/Depr 138.59%
Cap/Sales 5.93%
Interest Coverage 250
Cash Conversion 103.45%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.93
Altman-Z 1.93
F-Score3
WACC7.9%
ROIC/WACC0.46
Cap/Depr(3y)123.27%
Cap/Depr(5y)130.2%
Cap/Sales(3y)4.01%
Cap/Sales(5y)4.66%
Profit Quality(3y)139.02%
Profit Quality(5y)124.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-61.51%
EPS 3Y-29.4%
EPS 5Y-7.75%
EPS Q2Q%-46.28%
EPS Next Y-63.95%
EPS Next 2Y-27.89%
EPS Next 3Y-10.79%
EPS Next 5Y5.03%
Revenue 1Y (TTM)-20.07%
Revenue growth 3Y-4.43%
Revenue growth 5Y3.02%
Sales Q2Q%-25.14%
Revenue Next Year-25.58%
Revenue Next 2Y-14.15%
Revenue Next 3Y-9.56%
Revenue Next 5Y-6.25%
EBIT growth 1Y-60.92%
EBIT growth 3Y-27.96%
EBIT growth 5Y-7.79%
EBIT Next Year-10.24%
EBIT Next 3Y6.13%
EBIT Next 5Y10.29%
FCF growth 1Y-79.05%
FCF growth 3Y-29.85%
FCF growth 5Y-2.67%
OCF growth 1Y-47.04%
OCF growth 3Y-20.83%
OCF growth 5Y-5.1%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 3 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to decline by -63.95% in the next year.